首页> 外文期刊>International Journal of Pharmaceutics >Application of the design of experiments in optimization of drug layering of pellets with an insight into drug polymer interactions
【24h】

Application of the design of experiments in optimization of drug layering of pellets with an insight into drug polymer interactions

机译:实验设计在优化小丸药物分层中的应用,深入了解药物聚合物之间的相互作用

获取原文
获取原文并翻译 | 示例
       

摘要

This study consists of two experimental designs. Within the first one, suitable technique for application of model drug onto inactive pellets was evaluated and formulation and process parameters with greatest impact to process efficency and useful yield were determined. Results of experiments showed that formulation characteristics were the ones with the greatest impact on coating efficiency and that suspension layering technique was significantly better for drug application onto inactive pellets in comparison to solution layering during which pronounced agglomeration of pellets occurred. Analysis of drug-polymer interactions by differential scanning calorimetry was performed to explain the results of experiments. The reason for agglomeration of pellets during solution layering was formation of low Tg amorphous form of model drug. The second set of experiments was performed according to central composite design experimental plan in order to optimize level of binder and concentration of solids in the coating liquid which were found to have greatest positive impact on process efficiency and useful yield in the screening study. Statistically significant models were obtained by response surface methodology and it was possible to use them to define optimal levels of excipients in the formulation. (c) 2016 Published by Elsevier B.V.
机译:这项研究包括两个实验设计。在第一个方法中,评估了将模型药物应用于非活性小球的合适技术,并确定了对工艺效率和有用收率影响最大的配方和工艺参数。实验结果表明,制剂特征是对包衣效率影响最大的特征,并且与在溶液中发生明显团聚的溶液分层相比,悬浮分层技术对于药物在非活性小丸上的应用明显更好。通过差示扫描量热法进行药物-聚合物相互作用的分析以解释实验结果。溶液分层过程中颗粒团聚的原因是形成低Tg无定形形式的模型药物。第二组实验是根据中央复合设计实验计划进行的,目的是优化粘合剂水平和涂料液中的固体浓度,这在筛选研究中对工艺效率和有用的收率具有最大的积极影响。通过响应面方法获得了具有统计学意义的模型,可以使用它们来定义制剂中赋形剂的最佳水平。 (c)2016年由Elsevier B.V.发布

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号